See more : Ilyang Pharmaceutical Co.,Ltd (007570.KS) Income Statement Analysis – Financial Results
Complete financial analysis of ICC Holdings, Inc. (ICCH) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of ICC Holdings, Inc., a leading company in the Insurance – Specialty industry within the Financial Services sector.
- CAT Strategic Metals Corporation (CAT.CN) Income Statement Analysis – Financial Results
- Jagsonpal Pharmaceuticals Limited (JAGSNPHARM.BO) Income Statement Analysis – Financial Results
- Senthil Infotek Limited (SENINFO.BO) Income Statement Analysis – Financial Results
- Cascadia Acquisition Corp. (CCAIU) Income Statement Analysis – Financial Results
- Oramed Pharmaceuticals Inc. (ORMP.TA) Income Statement Analysis – Financial Results
ICC Holdings, Inc. (ICCH)
About ICC Holdings, Inc.
ICC Holdings, Inc., together with its subsidiaries, provides property and casualty insurance products to the food and beverage industry in the United States. The company offers commercial multi-peril, liquor liability, workers' compensation, and umbrella liability insurance products. It markets its products through a network of 186 independent agents in Arizona, Colorado, Illinois, Indiana, Iowa, Kansas, Minnesota, Michigan, Missouri, Ohio, Oregon, Pennsylvania, Tennessee, Utah, and Wisconsin. ICC Holdings, Inc. was founded in 1950 and is headquartered in Rock Island, Illinois.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 82.94M | 69.68M | 61.44M | 54.88M | 59.52M | 51.16M | 48.18M | 44.87M | 41.82M | 39.83M |
Cost of Revenue | 1.78B | 1.73B | 1.68B | 1.44B | 1.75B | 18.21B | 17.31B | 0.00 | 0.00 | 0.00 |
Gross Profit | -1.70B | -1.66B | -1.62B | -1.39B | -1.69B | -18.16B | -17.26B | 44.87M | 41.82M | 39.83M |
Gross Profit Ratio | -2,047.77% | -2,386.35% | -2,629.37% | -2,523.84% | -2,838.53% | -35,501.39% | -35,824.37% | 100.00% | 100.00% | 100.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 784.31K | 776.75K | 723.35K | 641.76K | 579.71K | 545.99K | 555.11K | 464.38K | 314.12K | 263.48K |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 784.31K | 776.75K | 723.35K | 641.76K | 579.71K | 545.99K | 555.11K | 464.38K | 314.12K | 263.48K |
Other Expenses | 82.16M | 1.77M | -57.55M | -50.71M | -54.97M | -50.57M | 17.26B | -41.35M | -39.12M | -37.73M |
Operating Expenses | 82.94M | 1.77M | -56.83M | -50.07M | -54.39M | -50.02M | 17.26B | -40.88M | -38.81M | -37.47M |
Cost & Expenses | 82.94M | 70.40M | 56.48M | 50.30M | 54.44M | 50.16M | 47.09M | 40.88M | 38.81M | 37.47M |
Interest Income | 0.00 | 196.07K | 235.00K | 207.72K | 128.79K | 0.00 | 0.00 | 0.00 | 2.33M | 2.15M |
Interest Expense | 184.12K | 196.07K | 235.00K | 207.72K | 128.79K | 140.88K | 225.38K | 226.10K | 136.30K | 133.78K |
Depreciation & Amortization | 763.82K | 693.07K | 708.38K | 684.74K | 794.51K | 733.49K | 822.62K | 817.77K | 505.56K | 511.29K |
EBITDA | 6.47M | 167.31K | 5.32M | 5.47M | 5.93M | 1.87M | 2.13M | 5.03M | 3.66M | 3.01M |
EBITDA Ratio | 7.80% | -0.75% | 8.65% | 10.01% | 9.96% | 3.66% | 4.42% | 11.21% | 8.75% | 7.56% |
Operating Income | 0.00 | -1.22M | 4.61M | 4.81M | 5.13M | 1.14M | 1.09M | 3.99M | 3.02M | 2.36M |
Operating Income Ratio | 0.00% | -1.75% | 7.50% | 8.76% | 8.63% | 2.23% | 2.26% | 8.89% | 7.21% | 5.94% |
Total Other Income/Expenses | 5.52M | -196.07K | 1.56B | 1.43M | 1.65B | -140.88K | -225.38K | -226.10K | -136.30K | -133.78K |
Income Before Tax | 5.52M | -721.83K | 4.96M | 4.58M | 5.08M | 999.38K | 1.09M | 3.99M | 3.02M | 2.36M |
Income Before Tax Ratio | 6.66% | -1.04% | 8.07% | 8.34% | 8.54% | 1.95% | 2.26% | 8.89% | 7.21% | 5.94% |
Income Tax Expense | 1.27M | -250.48K | 667.73K | 1.05M | 787.22K | 106.09K | 372.29K | 1.18M | 861.74K | 779.15K |
Net Income | 4.26M | -471.34K | 4.14M | 3.53M | 4.29M | 893.30K | 716.76K | 2.81M | 2.15M | 1.59M |
Net Income Ratio | 5.13% | -0.68% | 6.74% | 6.43% | 7.21% | 1.75% | 1.49% | 6.26% | 5.15% | 3.98% |
EPS | 1.44 | -0.16 | 1.36 | 1.17 | 1.43 | 0.29 | 0.22 | 0.80 | 0.62 | 0.45 |
EPS Diluted | 1.43 | -0.16 | 1.35 | 1.16 | 1.42 | 0.29 | 0.22 | 0.80 | 0.62 | 0.45 |
Weighted Avg Shares Out | 2.95M | 3.03M | 3.05M | 3.03M | 3.01M | 3.12M | 3.16M | 3.50M | 3.50M | 3.50M |
Weighted Avg Shares Out (Dil) | 2.97M | 3.03M | 3.07M | 3.04M | 3.01M | 3.12M | 3.16M | 3.50M | 3.50M | 3.50M |
ICC HOLDINGS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of ICC Holdings, Inc. - ICCH
ICC Holdings, Inc. Reports 2024 Third Quarter and Nine Months Results
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ICCH and INSI on Behalf of Shareholders
ICCH Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of ICC Holdings, Inc. Is Fair to Shareholders
IndusInd Bank Provides One-of-its Kind Experience to Cricket Fans Through the Anthem Buddies Programme at the Ongoing ICC Men's T20 World Cup 2024
Shareholder Alert: Ademi LLP investigates whether ICC Holdings, Inc. has obtained a Fair Price for its Public Shareholders
ICC HOLDINGS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of ICC Holdings, Inc. - ICCH
ICC Holdings Confirms Withdrawal of Stilwell Group Director Nomination
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DO, ICCH on Behalf of Shareholders
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates Merger of ICC Holdings, Inc. - ICCH
Source: https://incomestatements.info
Category: Stock Reports